Literature DB >> 8396283

In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant.

K L Poffenberger1, P E Raichlen, R C Herman.   

Abstract

We report the construction of a deletion mutant (del22Z) that is unable to synthesize any detectable messenger RNA or protein products from the herpes simplex virus type 1 (HSV-1) immediate early ICP22 gene upon infection. The del22Z deletion mutant lacks all but 18 nucleotides of the ICP22 coding sequence and carries the bacterial lacZ gene at the site of the deletion. No other known open reading frames or flanking sequences were disrupted. Del22Z was able to infect Vero cells productively but was severely restricted in human and rodent cells that were permissive for the parental HSV-1(F). The yield of del22Z was not enhanced significantly, either by increasing the multiplicity of infection or by increasing the duration of the infection. There was a prolonged expression of some early gene products and a delayed appearance of some late gene products in both permissive and restrictive cells. This phenotype of cell-line restricted growth and alteration of the normal gene expression cascade maps specifically to the ICP22 coding region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396283     DOI: 10.1007/bf01702397

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  41 in total

1.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

Authors:  D A Leib; D M Coen; C L Bogard; K A Hicks; D R Yager; D M Knipe; K L Tyler; P A Schaffer
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

2.  Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; D H Brauer
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

3.  Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the alpha 47 gene.

Authors:  R Longnecker; B Roizman
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.

Authors:  W R Sacks; P A Schaffer
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

6.  Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component.

Authors:  R J Watson; M Sullivan; G F Vande Woude
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

7.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

8.  A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis.

Authors:  R J Watson; J B Clements
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

9.  Expression of immediate-early genes in herpes simplex virus type 1-infected XC cells: lack of ICP22 (68K) polypeptide.

Authors:  B Jacquemont; B Verrier; A L Epstein; I Machuca
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

10.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

Authors:  W R Sacks; C C Greene; D P Aschman; P A Schaffer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  35 in total

1.  Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated alpha-globin pre-mRNA in infected HeLa cells.

Authors:  P Cheung; K S Ellison; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.

Authors:  W O Ogle; B Roizman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

4.  Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0.

Authors:  Gillian Elliott; Wali Hafezi; Alison Whiteley; Emmanuelle Bernard
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions.

Authors:  Joseph S Orlando; John W Balliet; Anna S Kushnir; Todd L Astor; Magdalena Kosz-Vnenchak; Stephen A Rice; David M Knipe; Priscilla A Schaffer
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus.

Authors:  J Jason Bowman; Joseph S Orlando; David J Davido; Anna S Kushnir; Priscilla A Schaffer
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

8.  Repression of host RNA polymerase II transcription by herpes simplex virus type 1.

Authors:  C A Spencer; M E Dahmus; S A Rice
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

9.  Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames.

Authors:  M S Parcells; A S Anderson; J L Cantello; R W Morgan
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Identification and characterization of the ICP22 protein of equine herpesvirus 1.

Authors:  V R Holden; G B Caughman; Y Zhao; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.